Is AQST or ARTL more undervalued in 2026?

CirclFi compares Aquestive Therapeutics, Inc. (AQST) and Artelo Biosciences, Inc. (ARTL) using 13 institutional-grade valuation models. AQST has a Quality of Company score of 5.7/10 while ARTL scores 3.9/10.

Which is a better buy — AQST or ARTL?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AQST and ARTL valuations compare?

AQST at $4.02 and ARTL at $1.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AQST vs ARTL Valuation Comparison 2026 — Intrinsic Value Analysis

AQST

Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$4.02

Last close

Models

10/13

Active

ARTL

Pharmaceutical Preparations

Artelo Biosciences, Inc.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$1.40

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	AQST Fair Value	AQST Upside	ARTL Fair Value	ARTL Upside
Bayesian DCF	Intrinsic	$1.38	-65.6%	$2.59	+84.7%
Earnings Power Value	Intrinsic	$1.22	-70.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.06	-98.6%	$3.99	+184.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AQST vs ARTL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AQST vs ARTL — Which Stock Is More Undervalued?

AQST scores higher with a 5.7/10 quality rating vs ARTL's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aquestive Therapeutics, Inc. (AQST) and Artelo Biosciences, Inc. (ARTL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AQST currently trades at $4.02 with a QOC of 5.7/10, while ARTL trades at $1.40 with a QOC of 3.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).